Ep 217 - Weaning the wheezy child with David James at the PREMIER Conference
Jun 13, 2023
auto_awesome
PEM Consultant David James challenges current practices in weaning plans for wheezy children. He emphasizes personalized asthma treatment and avoiding overuse of short-acting beta agonists. By implementing a weaning plan for sub-utilization in children with respiratory issues, there was a notable reduction in sub-use rates, highlighting the significance of education and patient empowerment in healthcare outcomes.
Tailoring reliever therapy for wheezy children based on symptoms leads to decreased sabbutamol usage rates without compromising care.
Implementing a flexible weaning plan for sabbutamol in children results in reduced usage and positive family engagement.
Deep dives
Rethinking Sabbutamol Weaning Plans
The podcast discusses the concept of sabbutamol weaning plans for wheezy children, emphasizing a shift away from traditional fixed-dose approaches. David James challenges the common practice, highlighting the lack of evidence supporting these weaning plans. By examining outcomes in the UK compared to other countries, a connection is made between sabbutamol overuse and adverse asthma outcomes. The podcast advocates for tailoring reliever therapy based on individual symptoms rather than rigid dosing guidelines. Implementing a more flexible approach led to a significant reduction in sabbutamol usage rates without compromising patient care.
Patient Empowerment and Positive Reception
The podcast addresses the initial hesitation towards implementing changes in sabbutamol dosing and the success in engaging families in the new approach. By allowing families to assess and administer sabbutamol based on specific signs and symptoms, a notable decrease in sabbutamol usage was achieved with no increase in emergency department reattendances. Families appreciated the choice and the educational aspect of monitoring symptoms, indicating a positive response to the revised weaning plan.
Shifting Paradigms in Asthma Management
The episode delves into broader trends in asthma management, advocating for a reduction in reliance on short-acting beta agonists like sabbutamol. The discussion highlights a growing consensus among experts to move towards low-dose inhaled steroids or combination therapies for long-term asthma control. The focus shifts towards personalized care and proactive strategies, such as maintenance therapy, to manage asthma more effectively and reduce the need for short-acting beta agonists in viral wheezing cases.
David James has been a PEM Consultant at University Hospital Southampton since 2018. His main interests are in training and education, adolescent emergency medicine and Quality Improvement. He is the Divisional Director of Medical Education and a Training advisor on the PEMISAC. He is the acute care lead for Wessex Healthier Together and has led several projects including those around acute wheeze at UHS and regionally. Outside of work he enjoys swimming, cycling and running and is extremely average at triathlons.
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode